Policy

Expanding screening for hepatitis C virus infection may generate substantial benefits for patients and society, but only when paired with expanded treatment policies.

This special issue presents important new peer-reviewed research, covering issues ranging from access and the out-of-pocket costs of a treatment course, to the real-world consequences-both economic and clinical-of failing to treat.

Member cost negatively affects initial medication adherence and manufacturer coupons can decrease member share by up to 98%.

In the treatment of hepatitis C virus, the gap between efficacy and real-world effectiveness narrows with improved tolerability and ease of use.

This study analyzes the current coverage designs for hepatitis C virus drugs by Medicare Part D plans.

This study analyzes the effect of a managed care program on Medicaid expenditures for children with special healthcare needs using a quasi-experimental design.

An opportunity exists to better understand healthcare utilization patterns by low-income workers, which may contribute significantly to employer healthcare cost trend and lost workforce productivity.

On average, the health coach intervention cost $483 per participant per year. There was no evidence that the coaching intervention saved money at 1 year.